Free U.S. shipping $175+

ARA-290 — Novaryn Research
Hover to zoom
Recovery & StructuralSynthetic research compound

ARA-290

$69.99
10 mg

ARA-290 is an 11-amino-acid peptide derived from the helix B region of erythropoietin.

It was designed to engage the innate repair receptor — a heteromeric complex of the EPO receptor and the beta-common receptor — without the erythropoietic activity of the parent hormone. That separation is precisely why it is studied: it allows researchers to isolate tissue-protective receptor signaling from red-cell effects in preclinical models.

Research areas
Innate repair receptor signalingErythropoietin pathway researchCytoprotection studiesPreclinical research
Form: Lyophilized (freeze-dried)
Compound class
Synthetic research compound
Research category
Recovery & Structural
SKU
NVR-ARA-290-10MG
Appearance
Lyophilized powder
Storage
Store lyophilized at −20 °C. Protect from light and moisture.
Research use only
Strength
10 mg$69.99$7.00/mg
1
$69.99per 10 mg$7.00/mg

For research use only — not for human or animal consumption.

Supplied solely for legitimate laboratory and research purposes. Not for medical or veterinary use, diagnosis, treatment, or prevention of disease.

Research Grade
Batch Documentation
Research Use Only
U.S.-Based Fulfillment
What you should know

More detail on ARA-290.

Analytical values reflect per-lot documentation and appear once a batch is released.

Compound
Erythropoietin engages two distinct receptor arrangements: the classical homodimeric EPO receptor and a heteromeric complex associated with tissue-protective signaling. ARA-290 was developed from the helix B domain to bias toward the latter. Laboratory applications include receptor-selectivity assays, cytoprotection models in cultured cells, and preclinical neuropathy and inflammation research. Because the peptide is short and non-erythropoietic in published models, it is a useful control when distinguishing receptor pathways within the EPO family. Research use only.
Peptide class
Synthetic research compound
Mechanism (research context)
Extended mechanistic characterization for this compound is available in the published literature. Consult peer-reviewed references for detailed pathway analysis.
Why it is studied
ARA-290 is studied within its research category (Recovery & Structural) as a defined-sequence reference compound for laboratory investigation.
Current areas of research
Innate repair receptor signalingErythropoietin pathway researchCytoprotection studiesPreclinical research

Topics reflect published preclinical and in vitro research. Reference only — not a claim of clinical outcomes.

Scientific background

ARA-290 is supplied for in vitro laboratory research. Batch-specific analytical documentation is provided when available for the released lot.

Related

Related research materials

View all →
ARA-290
10 mg · $69.99
Notify me when available